Enfusion, Inc. (ENFN)

Market Cap	797.97M
Revenue (ttm)	163.36M
Net Income (ttm)	5.61M
Shares Out	88.96M
EPS (ttm)	0.08
PE Ratio	112.13
Forward PE	41.32
Dividend	n/a
Ex-Dividend Date	n/a

Volume	143,413
Open	8.92
Previous Close	8.86
Day's Range	8.91 - 9.12
52-Week Range	7.37 - 14.61
Beta	n/a
Analysts	Hold
Price Target	10.50 (+17.06%)
Earnings Date	Nov 9, 2023

About ENFN

Enfusion, Inc. provides software-as-a-service solutions for investment management industry in the United States, Europe, the Middle East, Africa, and the Asia Pacific. The company provides portfolio management system, which generates a real-time investment book of record that consists of valuation and risk tools that allows users to analyze aggregated or decomposed portfolio data for chief investment officers (CIOs) and portfolio managers; and order and execution management system that enables portfolio managers, traders, compliance teams, and ...

• Industry: Software - Application
• Sector: Technology
• IPO Date: Oct 21, 2021
• Employees: 1,006
• Stock Exchange: NYSE
• Ticker Symbol: ENFN

Financial Performance

In 2022, Enfusion's revenue was $150.35 million, an increase of 34.60% compared to the previous year's $111.70 million. Losses were -$7.65 million, -95.17% less than in 2021.

Analyst Forecast

According to 6 analysts, the average rating for ENFN stock is "Hold." The 12-month stock price forecast is $10.5, which is an increase of 17.06% from the latest price.

Price Target

$10.5

(17.06% upside)

Analyst Consensus: Hold